CONDITIONALLY ACTIVE POLYPEPTIDES Russian patent published in 2020 - IPC C07K16/00 A61K38/43 

Abstract RU 2735023 C2

FIELD: biotechnology.

SUBSTANCE: invention represents a method for obtaining from a parental antibody or antigen-binding antibody fragment, an antibody or antibody fragment, having a condition-dependent binding activity with an antigen, wherein said antibody or antibody fragment comprises at least three CDRs of the parent antibody, providing the ability to recognize and bind the antigen, as well as containing a mutation relative to the parent antibody, wherein said binding activity is measured in the analyzes, conducted at first and second values of said condition, wherein said condition-dependent binding activity depends on both first and second conditions values, at which activity is measured, and also depends on concentration of compound or ion, having molecular weight less than 100 amu, selected from bicarbonate, acetate, lactate, bisulphate, hydrogen sulphide, ammonium, sodium sulphide and any combination thereof.

EFFECT: invention enables efficient production of antibodies.

12 cl, 9 dwg, 4 tbl, 15 ex

Similar patents RU2735023C2

Title Year Author Number
CONDITIONALLY ACTIVE BIOLOGICAL PROTEINS 2016
  • Short Dzhej M.
  • Chan Khvaj Ven
  • Frej Gerkhard
RU2733658C2
CONDITIONALLY ACTIVE CHIMERIC ANTIGENIC RECEPTORS FOR MODIFIED T CELLS 2016
  • Short, Dzhej, M.
RU2759957C2
CONDITIONALLY ACTIVE CHIMERIC ANTIGEN RECEPTORS FOR MODIFIED T-CELLS 2015
  • Short, Jay M.
RU2764074C2
IDENTIFICATION, ASSESSMENT, AND THERAPY OF CANCERS WITH INNATE OR ACQUIRED RESISTANCE TO ALK INHIBITORS 2011
  • Mano Khiroyuki
  • Choj Yang L.
  • Soda Manabu
RU2589834C2
ALPHA-ENOLASE SPECIFIC ANTIBODIES AND METHODS OF USES IN CANCER THERAPY 2013
  • Tsaj Shi-Chun
  • Shi Nen-Yao
  • Yuan Ta-Tun
  • Lyu Ko-Tszyunn
  • Tsen Shi-Chi
  • Khu Chi-Yun
  • Van Khsin-Yun
  • Chen Li-Ttszun
RU2656153C1
SPECIFIC BINDING PROTEINS AND APPLICATIONS THEREOF 2010
  • Old, Llojd, Dzh.
  • Dzhons, Terrans, Grant
  • Panousis, Kon
  • Skott, Ehndrju, Mark
  • Renner, Kristof
  • Ritter, Gerd
  • Jungblut, Akhim
  • Shtokkert, Ehlizabet
  • Kollinz, Piter
  • Kejvini, Uehbster, K.
  • Khuan, Khuehj-Dzen Su
  • Berdzhess, Ehntoni Uilks
  • Najs, Ehduard Kollinz
  • Mjurrehj, Ehnn
  • Mark, Dzhordzh
RU2549678C2
HETEROMULTIMERS WITH REDUCED OR SILENCED EFFECTOR FUNCTION 2014
  • Escobar-Cabrera Eric
RU2655439C2
ANTIBODIES SPECIFIC TO TUMOUR AND USE THEREOF 2011
  • Makerdzhi Pinku
RU2595403C2
MONOCLONAL PD-L1 ANTIBODY 2017
  • Ulitin Andrej Borisovich
  • Ekimova Viktoriya Mikhajlovna
  • Sofronova Ekaterina Vladimirovna
  • Chernykh Yuliya Sergeevna
  • Ageev Sergej Andreevich
  • Vladimirova Anna Konstantinovna
  • Aleksandrov Aleksej Aleksandrovich
  • Grebnev Pavel Alekseevich
  • Solovev Valerij Vladimirovich
  • Ustyugov Yakov Yurevich
  • Yakovlev Pavel Andreevich
  • Nemankin Timofej Aleksandrovich
  • Morozov Dmitrij Valentinovich
RU2665790C1
ANTIBODIES AGAINST TENB2 CONSTRUCTED WITH CYSTEINE, AND CONJUGATES, ANTIBODY-DRUG 2008
  • Mao Vehjguan
  • Dzhunutula Dzhagatkh Reddi
  • Polakis Pol
RU2505544C2

RU 2 735 023 C2

Authors

Short Dzhej M.

Chan Khvaj Ven

Frej Gerkhard

Dates

2020-10-27Published

2016-08-31Filed